No patients died of prostate cancer. The 5-year overall survival was 90%.
For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...
The 2025 ASTRO annual meeting featured a prostate cancer radiation toxicity session and a presentation by Dr. Young Suk Kwon discussing an EPIC-26 longitudinal analyses of prostatic urethral lift ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback